. 2019 Oct 15;24(20):3709. doi: 10.3390/molecules24203709

Table 5.

A summary of potential therapeutic approaches for schizophrenia by targeting the kynurenine pathway (KP) and ECS.

Approaches	References
*Kynurenine pathway*
KAT II inhibition	[22,23,24,25,27]
IDO, TDO KMO inhibition	[7,26,263]
*ECS*
FAAH inhibition (including CBD)	[264,265,266,267,268,269,270,271]
CB₁R activation	[272]
CB₁R blockade	[273,274,275]